SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

Segluromet 7.5 mg/1 is primarily used for managing type 2 diabetes in adults. It works by combining two active ingredients, ertugliflozin and metformin hydrochloride, to help regulate blood sugar levels. This medication is often prescribed alongside diet and exercise to improve glycemic control. People often ask, 'What is Segluromet used for?' and the answer is that it is designed to assist in the management of type 2 diabetes.

Common effects of Segluromet 7.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some users might experience urinary tract infections or low blood sugar. These effects can vary among individuals and are not exhaustive.

Segluromet 7.5 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use, especially for those with kidney issues or a history of lactic acidosis. Always store the medication as directed and keep it out of reach of children.

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, corticosteroids, and some blood pressure drugs. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications you are taking.